{"id":5792,"date":"2018-06-26T09:00:00","date_gmt":"2018-06-26T09:00:00","guid":{"rendered":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/"},"modified":"2024-09-23T11:22:33","modified_gmt":"2024-09-23T11:22:33","slug":"insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa","status":"publish","type":"post","link":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/","title":{"rendered":"Insulinepomp Medtronic 670G ontvangt CE Markering in Europa"},"content":{"rendered":"<a href=\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2018\/06\/MG_7875_sc.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-7485 size-medium\" src=\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/MG_7875_sc-300x200-2.jpg\" alt=\"\" width=\"300\" height=\"200\" \/><\/a>Gisteren werd bekend dat de nieuwste insulinepomp van Medtronic, de 670G pomp, goedgekeurd is voor gebruik bij mensen met Type 1 Diabetes vanaf 7 jaar oud. Dit is het eerste \u2018hybride closed loop systeem\u2019, waarbij de basaalstand automatisch wordt aangepast op basis van de bloedglucosewaarden die via een CGM zijn verkregen. Hiermee komen we een stap dichterbij een volledige kunstmatige alvleesklier.\n\nEen kunstmatige alvleesklier is technologie bestaande uit een insulinepomp, continue glucose meter (CGM) en een algoritme waardoor je bloedglucosespiegel automatisch binnen de gewenste waarden wordt gehouden. We werken toe naar een systeem waarbij handmatig ingrijpen helemaal niet meer nodig is: je pomp en sensor kunnen zelf bepalen wanneer meer of minder insuline nodig is en hypo\u2019s en hypers zijn verleden tijd.\n\nDeze nieuwe pomp is weer een stap in de goede richting. De pomp stopt met de afgifte van de basaalinsuline als er een hypo dreigt, en geeft meer basale insuline af bij te hoge waardes. Zo wordt de \u2018Time in Range\u2019, de tijd dat de bloedglucosewaardes tussen de 3,9 en 10.0 mmol\/l zit, verbeterd. Je moet nog wel steeds zelfstandig insuline toedienen bij de maaltijd en, doordat het systeem alleen wijzigt in je basale insuline, kunnen hele snelle stijgingen of dalingen nog steeds plaatsvinden. Vergeet je bijvoorbeeld te eten maar heb je al wel gebolust, zal het systeem je hypo mogelijk niet kunnen voorkomen.\n\nDe Medtronic 670G pomp zal vanaf het najaar verkrijgbaar zijn in Europa. Wanneer het systeem precies in Nederland beschikbaar komt is nog niet bekend.\n\n<hr \/><h3><a href=\"https:\/\/breakthrought1d.eu\/nl\/nieuwsbrief\/\">Wil jij altijd op de hoogte gehouden worden van alle onderzoeken en ontwikkelingen rond Type 1 Diabetes? Meld je aan voor onze nieuwsbrief.<\/a><\/h3>","protected":false,"raw":""},"excerpt":{"rendered":"<p>Gisteren werd bekend dat de nieuwste insulinepomp van Medtronic, de 670G pomp, goedgekeurd is voor gebruik bij mensen met Type 1 Diabetes vanaf 7 jaar oud. Dit is het eerste \u2018hybride closed loop systeem\u2019, waarbij de basaalstand automatisch wordt aangepast op basis van de bloedglucosewaarden die via een CGM zijn verkregen. Hiermee komen we een [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[184],"tags":[],"class_list":["post-5792","post","type-post","status-publish","format-standard","hentry","category-archief"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Insulinepomp Medtronic 670G ontvangt CE Markering in Europa - Breakthrough T1D<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Insulinepomp Medtronic 670G ontvangt CE Markering in Europa - Breakthrough T1D\" \/>\n<meta property=\"og:description\" content=\"Gisteren werd bekend dat de nieuwste insulinepomp van Medtronic, de 670G pomp, goedgekeurd is voor gebruik bij mensen met Type 1 Diabetes vanaf 7 jaar oud. Dit is het eerste \u2018hybride closed loop systeem\u2019, waarbij de basaalstand automatisch wordt aangepast op basis van de bloedglucosewaarden die via een CGM zijn verkregen. Hiermee komen we een [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/\" \/>\n<meta property=\"og:site_name\" content=\"Breakthrough T1D\" \/>\n<meta property=\"article:published_time\" content=\"2018-06-26T09:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-23T11:22:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/MG_7875_sc-300x200-2.jpg\" \/>\n<meta name=\"author\" content=\"ylt-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"ylt-admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/\"},\"author\":{\"name\":\"ylt-admin\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\"},\"headline\":\"Insulinepomp Medtronic 670G ontvangt CE Markering in Europa\",\"datePublished\":\"2018-06-26T09:00:00+00:00\",\"dateModified\":\"2024-09-23T11:22:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/\"},\"wordCount\":278,\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/MG_7875_sc-300x200-2.jpg\",\"articleSection\":[\"Archief\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/\",\"name\":\"Insulinepomp Medtronic 670G ontvangt CE Markering in Europa - Breakthrough T1D\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/MG_7875_sc-300x200-2.jpg\",\"datePublished\":\"2018-06-26T09:00:00+00:00\",\"dateModified\":\"2024-09-23T11:22:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/#primaryimage\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2019\/10\/aanbieden-petitie-sensorvergoeding.jpg\",\"contentUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2019\/10\/aanbieden-petitie-sensorvergoeding.jpg\",\"width\":500,\"height\":450},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/breakthrought1d.eu\/nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Insulinepomp Medtronic 670G ontvangt CE Markering in Europa\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"name\":\"Breakthrough T1D\",\"description\":\"Wij zetten ons in voor een toekomst zonder T1D\",\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\",\"name\":\"Breakthrough T1D\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"contentUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"width\":330,\"height\":141,\"caption\":\"Breakthrough T1D\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\",\"name\":\"ylt-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"caption\":\"ylt-admin\"},\"sameAs\":[\"https:\/\/87.250.144.92\"],\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Insulinepomp Medtronic 670G ontvangt CE Markering in Europa - Breakthrough T1D","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/","og_locale":"nl_NL","og_type":"article","og_title":"Insulinepomp Medtronic 670G ontvangt CE Markering in Europa - Breakthrough T1D","og_description":"Gisteren werd bekend dat de nieuwste insulinepomp van Medtronic, de 670G pomp, goedgekeurd is voor gebruik bij mensen met Type 1 Diabetes vanaf 7 jaar oud. Dit is het eerste \u2018hybride closed loop systeem\u2019, waarbij de basaalstand automatisch wordt aangepast op basis van de bloedglucosewaarden die via een CGM zijn verkregen. Hiermee komen we een [&hellip;]","og_url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/","og_site_name":"Breakthrough T1D","article_published_time":"2018-06-26T09:00:00+00:00","article_modified_time":"2024-09-23T11:22:33+00:00","og_image":[{"url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/MG_7875_sc-300x200-2.jpg","type":"","width":"","height":""}],"author":"ylt-admin","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"ylt-admin","Geschatte leestijd":"1 minuut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/#article","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/"},"author":{"name":"ylt-admin","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6"},"headline":"Insulinepomp Medtronic 670G ontvangt CE Markering in Europa","datePublished":"2018-06-26T09:00:00+00:00","dateModified":"2024-09-23T11:22:33+00:00","mainEntityOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/"},"wordCount":278,"publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/#primaryimage"},"thumbnailUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/MG_7875_sc-300x200-2.jpg","articleSection":["Archief"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/","url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/","name":"Insulinepomp Medtronic 670G ontvangt CE Markering in Europa - Breakthrough T1D","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/#primaryimage"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/#primaryimage"},"thumbnailUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/MG_7875_sc-300x200-2.jpg","datePublished":"2018-06-26T09:00:00+00:00","dateModified":"2024-09-23T11:22:33+00:00","breadcrumb":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/#primaryimage","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2019\/10\/aanbieden-petitie-sensorvergoeding.jpg","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2019\/10\/aanbieden-petitie-sensorvergoeding.jpg","width":500,"height":450},{"@type":"BreadcrumbList","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/insulinepomp-medtronic-670g-ontvangt-ce-markering-in-europa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/breakthrought1d.eu\/nl\/"},{"@type":"ListItem","position":2,"name":"Insulinepomp Medtronic 670G ontvangt CE Markering in Europa"}]},{"@type":"WebSite","@id":"https:\/\/breakthrought1d.eu\/nl\/#website","url":"https:\/\/breakthrought1d.eu\/nl\/","name":"Breakthrough T1D","description":"Wij zetten ons in voor een toekomst zonder T1D","publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/breakthrought1d.eu\/nl\/#organization","name":"Breakthrough T1D","url":"https:\/\/breakthrought1d.eu\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","width":330,"height":141,"caption":"Breakthrough T1D"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6","name":"ylt-admin","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","caption":"ylt-admin"},"sameAs":["https:\/\/87.250.144.92"],"url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5792","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/comments?post=5792"}],"version-history":[{"count":3,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5792\/revisions"}],"predecessor-version":[{"id":8913,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5792\/revisions\/8913"}],"wp:attachment":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/media?parent=5792"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/categories?post=5792"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/tags?post=5792"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}